The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Vasostatin, a Calreticulin Fragment, Inhibits Angiogenesis and Suppresses Tumor Growth
Open accessAbstract
An endothelial cell inhibitor was purified from supernatant of an Epstein-Barr virus–immortalized cell line and identified as fragments of calreticulin. The purified recombinant NH2-terminal domain of calreticulin (amino acids 1–180) inhibited the proliferation of endothelial cells, but not cells of other lineages, and suppressed angiogenesis in vivo. We have named this NH2-terminal domain of calreticulin vasostatin. When inoculated into athymic mice, vasostatin significantly reduced growth of human Burkitt lymphoma and human colon carcinoma. Compared with other inhibitors of angiogenesis, vasostatin is a small, soluble, and stable molecule that is easy to produce and deliver. As an angiogenesis inhibitor that specifically targets proliferating endothelial cells, vasostatin has a unique potential for cancer treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis
Hanahan, D., & Folkman, J. (1996) · Cell · doi:10.1016/s0092-8674(00)80108-7 · Cited by 6,885
Endostatin: an endogenous inhibitor of angiogenesis and tumor growth
O'Reilly, M. S., Boehm, T., Shing, Y., Fukai, N., Vasios, G., Lane, W. S., Flynn, E., Birkhead, J. R., Olsen, B. R., & Folkman, J. (1997) · Cell · doi:10.1016/s0092-8674(00)81848-6 · Cited by 4,486
Kim, K. J., Li, B., Winer, J., Armanini, M., Gillett, N., Phillips, H. S., & Ferrara, N. (1993) · Nature · doi:10.1038/362841a0 · Cited by 3,605
O'Reilly, M. (1994) · Cell · doi:10.1016/0092-8674(94)90200-3 · Cited by 3,345
Requirement of Vascular Integrin α v β 3 for Angiogenesis
Brooks, P. C., Clark, R. A. F., & Cheresh, D. A. (1994) · Science · doi:10.1126/science.7512751 · Cited by 3,020
Thalidomide is an inhibitor of angiogenesis.
D'Amato, R. J., Loughnan, M. S., Flynn, E., & Folkman, J. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.9.4082 · Cited by 2,454
Integrin αvβ3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels
Brooks, P. C., Montgomery, A. M. P., Rosenfeld, M., Reisfeld, R. A., Hu, T., Klier, G., & Cheresh, D. A. (1994) · Cell · doi:10.1016/0092-8674(94)90007-8 · Cited by 2,262
Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance
Boehm, T., Folkman, J., Browder, T., & O'Reilly, M. S. (1997) · Nature · doi:10.1038/37126 · Cited by 1,683
Kendall, R. L., & Thomas, K. A. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.22.10705 · Cited by 1,394
Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growth
Ingber, D., Fujita, T., Kishimoto, S., Sudo, K., Kanamaru, T., Brem, H., & Folkman, J. (1990) · Nature · doi:10.1038/348555a0 · Cited by 1,299
Characterization of Peptides Bound to the Class I MHC Molecule HLA-A2.1 by Mass Spectrometry
Hunt, D. F., Henderson, R. A., Shabanowitz, J., Sakaguchi, K., Michel, H., Sevilir, N., Cox, A. L., Appella, E., & Engelhard, V. H. (1992) · Science · doi:10.1126/science.1546328 · Cited by 1,198
Self-citationAngiostatin induces and sustains dormancy of human primary tumors in mice
O'Reilly, M. S., Holmgren, L., Chen, C., & Folkman, J. (1996) · Nature Medicine · doi:10.1038/nm0696-689 · Cited by 1,184
Good, D. J., Polverini, P. J., Rastinejad, F., Le Beau, M. M., Lemons, R. S., Frazier, W. A., & Bouck, N. P. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.17.6624 · Cited by 1,054
Inhibition of Angiogenesis In Vivo by Interleukin 12
Voest, E. E., Kenyon, B. M., O'Reilly, M. S., Truitt, G., D'Amato, R. J., & Folkman, J. (1995) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/87.8.581 · Cited by 722
Human interferon-inducible protein 10 is a potent inhibitor of angiogenesis in vivo.
Angiolillo, A. L., Sgadari, C., Taub, D. D., Liao, F., Farber, J. M., Maheshwari, S., Kleinman, H. K., Reaman, G. H., & Tosato, G. (1995) · The Journal of experimental medicine · doi:10.1084/jem.182.1.155 · Cited by 705
Self-citationInhibition of Angiogenesis by Recombinant Human Platelet Factor-4 and Related Peptides
Maione, T. E., Gray, G. S., Petro, J., Hunt, A. J., Donner, A. L., Bauer, S. I., Carson, H. F., & Sharpe, R. J. (1990) · Science · doi:10.1126/science.1688470 · Cited by 697
Cheresh, D. A., & Spiro, R. C. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)45436-1 · Cited by 565
Halting angiogenesis suppresses carcinoma cell invasion
Skobe, M., Rockwell, P., Goldstein, N., Vosseler, S., & Fusenig, N. E. (1997) · Nature Medicine · doi:10.1038/nm1197-1222 · Cited by 420
Michalak, M., Milner, R. E., Burns, K., & Opas, M. (1992) · Biochemical Journal · doi:10.1042/bj2850681 · Cited by 407
Integrin-associated Protein Is a Receptor for the C-terminal Domain of Thrombospondin
Gao, A.-G., Lindberg, F. P., Finn, M. B., Blystone, S. D., Brown, E. J., & Frazier, W. A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.1.21 · Cited by 402
Modulation of gene expression by calreticulin binding to the glucocorticoid receptor
Burns, K., Duggan, B., Atkinson, E. A., Famulski, K. S., Nemer, M., Bleackley, R. C., & Michalak, M. (1994) · Nature · doi:10.1038/367476a0 · Cited by 393
Calreticulin is essential for integrin-mediated calcium signalling and cell adhesion
Coppolino, M. G., Woodside, M. J., Demaurex, N., Grinstein, S., St-Arnaud, R., & Dedhar, S. (1997) · Nature · doi:10.1038/386843a0 · Cited by 390
The 16-kilodalton N-terminal fragment of human prolactin is a potent inhibitor of angiogenesis
Clapp, C., MARTIAL, J. A., Guzman, R. C., Rentier-Delure, F., & Weiner, R. I. (1993) · Endocrinology · doi:10.1210/en.133.3.1292 · Cited by 340
Krause, K.-H., & Michalak, M. (1997) · Cell · doi:10.1016/s0092-8674(00)81884-x · Cited by 315
Tannenbaum, C. S., Tubbs, R., Armstrong, D., Finke, J. H., Bukowski, R. M., & Hamilton, T. A. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.2.927 · Cited by 294
Strieter, R. M., Kunkel, S. L., Arenberg, D. A., Burdick, M. D., & Polverini, P. J. (1995) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1995.1626 · Cited by 287
ANGIOGENESIS: INITIATION AND CONTROL*
Folkman, J. (1982) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1982.tb25720.x · Cited by 262
Mig, the Monokine Induced By Interferon-γ, Promotes Tumor Necrosis In Vivo
Sgadari, C., Farber, J. M., Angiolillo, A. L., Liao, F., Teruya-Feldstein, J., Burd, P. R., Yao, L., Gupta, G., Kanegane, C., & Tosato, G. (1997) · Blood · doi:10.1182/blood.v89.8.2635 · Cited by 246
Self-citationInterferon-inducible protein-10 identified as a mediator of tumor necrosis in vivo
Sgadari, C., Angiolillo, A. L., Cherney, B. W., Pike, S. E., Farber, J. M., Koniaris, L. G., Vanguri, P., Burd, P. R., Sheikh, N., Gupta, G., et al. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.24.13791 · Cited by 217
Self-citationVolpert, O. V., Lawler, J., & Bouck, N. P. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.6343 · Cited by 186
Evidence that nitric oxide is an endogenous antiangiogenic mediator
Pipili‐Synetos, E., Sakkoula, E., Haralabopoulos, G., Andriopoulou, P., Peristeris, P., & Maragoudakis, M. E. (1994) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1994.tb14822.x · Cited by 163
Contribution of the CXC chemokines IP-10 and Mig to the antitumor effects of IL-12
Kanegane, C., Sgadari, C., Kanegane, H., Teruya‐Feldstein, J., Yao, L., Gupta, G. D., Farber, J. M., Liao, F., Liu, L., & Tosato, G. (1998) · Journal of Leukocyte Biology · doi:10.1002/jlb.64.3.384 · Cited by 159
Self-citationCalreticulin: not just another calcium-binding protein
Nash, P., Opas, M., & Michalak, M. (1994) · Molecular and Cellular Biochemistry · doi:10.1007/bf00925962 · Cited by 134
Kuwabara, K., Pinsky, D. J., Schmidt, A. M., Benedict, B., Brett, B., Ogawa, S., Broekman, M. J., Marcus, A. J., Sciacca, R. R., Michalak, M., et al. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.14.8179 · Cited by 78
Nitric Oxide Inhibits Migration of Cultured Endothelial Cells
Lau, Y., & Ma, W.-C. (1996) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1996.0654 · Cited by 76
Hanahan, D. (1998) · Nature Medicine · doi:10.1038/nm0198-013 · Cited by 63
Tosato, G., Gerrard, T. L., Goldman, N. G., & Pike, S. E. (1988) · The Journal of Immunology · doi:10.4049/jimmunol.140.12.4329 · Cited by 59
Self-citationHalting Angiogenesis Suppresses Carcinoma Cell Invasion
Skobe, M., Rockwell, P., Goldstein, N., Vosseler, S., & Fusenig, N. E. (1999) · The Journal of Urology · doi:10.1016/s0022-5347(05)68639-9 · Cited by 58
Pogue, G. P., Cao, X. Q., Singh, N., & Nakhasi, H. L. (1993) · Journal of Virology · doi:10.1128/jvi.67.12.7106-7117.1993 · Cited by 34
Self-citationThe rubella virus RNA binding activity of human calreticulin is localized to the N-terminal domain
Atreya, C. D., Singh, N., & Nakhasi, H. L. (1995) · Journal of Virology · doi:10.1128/jvi.69.6.3848-3851.1995 · Cited by 33
Self-citationTosato, G., Sgadari, C., Taga, K., et al. (1994) · Blood · doi:10.1182/blood.v83.3.776.776 · Cited by 30
Self-citationTosato, G., Marti, G. E., Yarchoan, R., Heilman, C. A., Wang, F., Pike, S. E., Korsmeyer, S. J., & Siminovitch, K. A. (1986) · The Journal of Immunology · doi:10.4049/jimmunol.137.6.2037 · Cited by 18
Self-citation
Cited by
Angiogenesis as a therapeutic target
Ferrara, N., & Kerbel, R. S. (2005) · Nature · doi:10.1038/nature04483 · Cited by 2,653
Tumor angiogenesis: past, present and the near future
Kerbel, R. S. (2000) · Carcinogenesis · doi:10.1093/carcin/21.3.505 · Cited by 976
Griffioen, A. W., & Molema, G. (2000) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01448-0 · Cited by 842
Calreticulin: one protein, one gene, many functions
Michalak, M., Corbett, E. F., Mesaeli, N., Nakamura, K., & Opas, M. (1999) · Biochemical Journal · doi:10.1042/0264-6021:3440281 · Cited by 830
CXC chemokines in angiogenesis
Belperio, J. A., Keane, M. P., Arenberg, D. A., Addison, C. L., Ehlert, J. E., Burdick, M. D., & Strieter, R. M. (2000) · Journal of Leukocyte Biology · doi:10.1189/jlb.68.1.1 · Cited by 804
Metadata
- Authors
- Pike, S. E., Yao, L., Jones, K. D., Cherney, B., Appella, E., Sakaguchi, K., Nakhasi, H., Teruya-Feldstein, J., Wirth, P., Gupta, G., & Tosato, G.
- Venue
- The Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 1998-12-21
- Volume
- 188
- Issue
- 12
- Pages
- 2349-2356
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2154061285
- Cited by
- 310
- References
- 42
- FWCI
- 4.73
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.